Chari, A., Touzeau, C., Schinke, C., Minnema, M., Berdeja, J. G., Oriol, A., . . . Moreau, P. (2025). Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): A multicentre, open-label, phase 1–2 study.
Citación estilo ChicagoChari, Ajai, et al. Safety and Activity of Talquetamab in Patients With Relapsed or Refractory Multiple Myeloma (MonumenTAL-1): A Multicentre, Open-label, Phase 1–2 Study. 2025.
Cita MLAChari, Ajai, et al. Safety and Activity of Talquetamab in Patients With Relapsed or Refractory Multiple Myeloma (MonumenTAL-1): A Multicentre, Open-label, Phase 1–2 Study. 2025.
Precaución: Estas citas no son 100% exactas.